NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast...
Transcript of NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast...
![Page 1: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/1.jpg)
NICE Pathways
Judith Richardson, Associate Director, Health and Social Care
Digital Health: design: develop: deploy: evaluate
Warwick
25th July 2013
![Page 2: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/2.jpg)
Overview
• The context for NICE Pathways
• Why pathways?
• What are NICE pathways?
• Where are we up to?
• What’s the future?
![Page 3: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/3.jpg)
NICE audiences… an expanding
remit
• Social care audience
• Local government, for
social care and public
health
![Page 4: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/4.jpg)
Trends in the market
• Rapid uptake of mobile devices as the platform
to access evidence
• Expectation that evidence is integrated at the
point of care
• Social media and on-line networking
• Open access, big data
![Page 5: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/5.jpg)
NICE Digital Strategy
• To provide seamless, customer-centric access to
our vast content
• Within cost effective and affordable systems
![Page 6: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/6.jpg)
Our digital system vision
![Page 7: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/7.jpg)
Key access routes to date
![Page 8: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/8.jpg)
Why pathways – what was the
issue? • A lot of guidance
• Different guidance programmes
• Difficult to find all relevant information on a
given topic
• Not always easy to see how guidance
from different programmes fits together
• No linking across related topics
![Page 9: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/9.jpg)
![Page 10: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/10.jpg)
Being part of the solution
• Which mirror the experience of health professionals..
• And make them accessible through NHS Evidence and the NICE website
• That follow a sequence of decisions/events..
• We array our guidance along a series of pathways..
Prevention Diagnosis
Treatment Rehabilitation/
palliation
![Page 11: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/11.jpg)
What are NICE pathways?
• Bring together related
guidance, between and
within topics
• Link other products –
Quality Standards,
implementation support
tools etc
• Provide a useful format for
multiple audiences – a
network of NICE information
Easier quicker access to the
evidence
![Page 12: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/12.jpg)
Overview of the Depression Pathway
![Page 13: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/13.jpg)
Links to other information
![Page 15: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/15.jpg)
![Page 16: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/16.jpg)
Preventing type 2 diabetes: population
and community interventions. NICE public
health guidance 35 (2011)
Preventing type 2 diabetes: risk
identification and interventions for
individuals at high risk. NICE public health
guidance 38 (2012)
NICE public health guidance
![Page 17: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/17.jpg)
Type 1 diabetes. NICE clinical guideline 15
(2004)
Diabetes in pregnancy. NICE clinical
guideline 63 (2008)
Type 2 diabetes footcare. NICE clinical
guideline 10 (2004)
Diabetic foot problems: inpatient
management. NICE clinical guideline 119
(2011)
Type 2 diabetes – newer agents. NICE
clinical guideline 87 (2009)
NICE clinical guidelines
![Page 18: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/18.jpg)
Long-acting insulin analogues. NICE
technology appraisal guidance 53 (2002)
Patient education models. NICE technology
appraisal guidance 60 (2003)
Insulin pump therapy. NICE technology
appraisal guidance 151 (2008)
Intravitreal implant for macular oedema. NICE
technology appraisal guidance 271 (2013)
Ranibizumab for macular oedema. NICE
technology appraisal guidance 274 (2013) Exenatide for type 2 diabetes. NICE technology
appraisal guidance 248 (2012)
Liraglutide for type 2 diabetes. NICE
technology appraisal guidance 203 (2010)
Long-acting insulin analogues. NICE
technology appraisal guidance 53 (2002)
Patient education models. NICE technology
appraisal guidance 60 (2003)
NICE technology appraisals
Intravitreal implant for macular oedema. NICE
technology appraisal guidance 271 (2013)
Ranibizumab for macular oedema. NICE
technology appraisal guidance 274 (2013)
![Page 19: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/19.jpg)
Allogeneic pancreatic islet cell transplant for
type 1 diabetes. NICE interventional procedure
guidance 257 (2008)
NICE interventional procedures
![Page 20: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/20.jpg)
![Page 21: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/21.jpg)
![Page 22: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/22.jpg)
![Page 23: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/23.jpg)
Where are we up to?
• 125 pathways
• 80% of clinical guidelines
• 95% of public health guidance
• 90% of quality standards
• 45% overall (includes guidance on drugs
and procedures)
![Page 24: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/24.jpg)
What’s the future?
• 90% of guidance accessible by end of
2013/14
• Network of evidence and other supporting
information
• Incorporation of social care
• Improved presentation and function
![Page 25: NICE Pathways - warwick.ac.uk · •To provide seamless, customer-centric access to our vast content ... (2012) Liraglutide for type 2 diabetes. NICE technology appraisal guidance](https://reader036.fdocuments.us/reader036/viewer/2022071218/605333220b687155a32bcc6f/html5/thumbnails/25.jpg)
Feedback from users...... “I’m impressed by the wide and
growing coverage of
pathways” Ambulance trust
operations manager
“We use NICE pathways
extensively and they are
very easy to use and
navigate, and provide
helpful information in a
useful format”. Public
health team
“NICE pathways are very
helpful. They are more
"enticing" than the
guidance”. Social care team “I think you just made NICE
easier for us." Pathways
user